Skip to main navigation Skip to search Skip to main content

Systemic 1-methyl, 4-phenyl, 1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates

  • M. Felice Ghilardi
  • , Eunyong Chung
  • , Ivan Bodis-Wollner
  • , Mark Dvorzniak
  • , Andrew Glover
  • , Marco Onofrj

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Following MPTP administration, 4 Cynomolgus monkeys developed a parkinsonian syndrome, accompanied by specific changes of both pattern visual evoked potential and electroretinogram. Retinal dopamine and dihydroxyphenylacetic acid contents were measured in the 4 MPTP-treated monkeys and in 3 normal monkeys. Dopamine and dihydroxyphenylacetic acid levels were significantly lower in the retinas of the MPTP-treated animals (p<0.001), suggesting that dopamine has a specific function in the visual system of primates.

Original languageEnglish
Pages (from-to)255-262
Number of pages8
JournalLife Sciences
Volume43
Issue number3
DOIs
StatePublished - 1988

Fingerprint

Dive into the research topics of 'Systemic 1-methyl, 4-phenyl, 1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates'. Together they form a unique fingerprint.

Cite this